Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
15 June 2022
Closing Date:
12 July 2022
Location(s):
BE BELGIQUE-BELGIË (BE Belgium/BELGIQUE-BELGIË)
Description:
Normal human immunoglobulin for intravenous administration

The market is for the supply of normal human immunoglobulin for intravenous administration at a concentration of 10%.

The market is for the supply of normal human immunoglobulin for intravenous administration at a concentration of 10%.

Download full details as .pdf
The Buyer:
Cliniques universitaires Saint Luc
CPV Code(s):
33600000 - Pharmaceutical products